Tabla de Contenidos: “…MAKING IMPORTANT DECISIONS -- Allocation of Research Funds -- Regulatory Decisions About Technologies -- Food and Drug Administration -- Third-Party Payers -- CONTINUING DEVELOPMENT OF TOTAL ARTIFICIAL HEARTS -- Considerations for the Next Decision Point -- OTHER RECOMMENDATIONS -- Future Development of Ventricular Assist Devices -- Clinical Trials and Patient Follow-up -- Clinical Trials -- Postmarketing Surveillance -- Posttrial Follow-up -- Fostering Collaborative Interdisciplinary Research -- Patients' Quality of Life and Treatment Preferences -- Research Needs -- Heart Failure Research -- Epidemiological Research -- Communication Among MCSS Researchers -- HOW THIS REPORT SHOULD BE USED -- REFERENCE -- Appendixes -- A History and Methods of This Evaluation -- ADDENDUM -- B A Chronology of the National Heart, Lung, and Blood Institute Artificial Heart Program and Related Events -- C Technological Opportunities and Barriers in the Development of Mechanical Circulatory Support Systems -- CURRENT STATE OF THE TECHNOLOGY IN MECHANICAL CIRCULATORY SUPPORT SYSTEMS -- Short-Term-Use Devices (fewer than 180 days) -- Total Artificial Heart -- Animal and Clinical Results -- Technological Development of Pneumatic Total Artificial Hearts -- Univentricular or Biventricular Assist Devices -- Pulsatile Devices (Sac/Diaphragm) -- Steady-Flow Devices -- Summary -- Permanent or Long-Term-Use Mechanical Circulatory Support Systems (more than 180 days) -- Unilateral Assist Devices -- In Vitro and In Vivo Test Results -- Permanent Total Artificial Hearts -- University of Utah System -- Nimbus/Cleveland Clinic System -- ABIOMED/Texas Heart System -- Pennsylvania State University System -- Non-U.S. Systems -- Summary -- CURRENT TECHNOLOGICAL BARRIERS TO DEVELOPMENT OF A SUCCESSFUL MECHANICAL CIRCULATORY SUPPORT SYSTEM -- What Is a Successful MCSS?…”

Tabla de Contenidos: “…Malaria -- Copyright -- Preface -- Acknowledgements -- LIAISON PANEL -- CONTRIBUTORS TO THE STUDY -- Contents -- Malaria -- 1 Conclusions and Recommendations -- DEFINING THE PROBLEM -- THE REPORT -- Background -- Organization -- Sponsorship -- CONCLUSIONS AND RECOMMENDATIONS -- Policy -- Commitment and Sustainability -- Surveillance -- Inter-Sectoral Cooperation -- New Tools for Malaria Control -- Coordination and Integration -- Malaria Research Priorities -- Research in Support of Available Control Measures -- Development of New Tools -- Malaria Control -- Organization of Malaria Control -- Paradigm Approach -- Management -- Monitoring and Evaluation -- Problem Solving (Optional Research) and Evaluation -- Training -- 2 Background -- MALARIA AS A DISEASE -- Clinical Aspects -- Immunity -- Role of Genetics -- DIAGNOSIS -- THE PARASITE -- Life Cycle -- Relapse and Recrudescence -- THE MOSQUITO -- Life Cycle -- Host-Seeking and Feeding Behavior -- THE ENVIRONMENT -- EPIDEMIOLOGY -- Geographic Distribution -- Transmission -- MALARIA CONTROL -- Drugs -- Source Reduction -- Larviciding -- Spraying -- Contact Reduction -- Vaccines -- BIBLIOGRAPHY -- 3 Overview -- PRE-COLUMBIAN HISTORY -- MALARIA IN AMERICA -- DISCOVERY OF QUININE -- DISCOVERY OF THE MALARIA PARASITE AND ITS LIFE CYCLE -- MALARIA AND THE MILITARY -- MALARIA CONTROL -- ERADICATION -- Background -- Eradication Campaign -- Financial Support for Eradication -- Eradication to Control -- 1970 to Present -- U.S. AND INTERNATIONAL SUPPORT FOR MALARIA ACTIVITIES -- United States -- U.S. …”

Tabla de Contenidos: “…(NMC) -- Reference -- PART V Data And Research -- 13 Data Systems -- HEALTH CARE FINANCING ADMINISTRATION -- U.S. RENAL DATA SYSTEM -- UNITED NETWORK FOR ORGAN SHARING -- NATIONAL END-STAGE RENAL DISEASE REGISTRY -- ADEQUACY OF DATA SYSTEMS -- RECOMMENDATIONS -- NOTES -- REFERENCES -- 14 Research Needs -- REFERENCES -- APPENDIXES -- A Glossary -- B Acronyms and Initialisms -- C Commissioned Papers and Contractor Reports -- Intergovernmental Health Policy Project, George Washington University -- Medical Media Associates, Inc. -- Urban Institute -- D Survival Analysis Methods for the End-Stage Renal Disease (ESRD) Program of Medicare -- GENERAL ISSUES IN SURVIVAL ANALYSIS -- Overview -- Examples -- Identification of the Study Population -- The Importance of a Comparison Group -- Biased Comparisons…”

Materias: “…Institute of Medicine (U.S.). Committee to Study the Use of Advisory Committees by the Food and Drug Administration…”